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1. Introduction 
Comparison of the N-terminal sequence of the 
ACTH/LPH precursor proopiomelanocortin [l] 
deduced from the bovine cDNA [2] with the sequence 
determined for rat pars intermedia precursor [l] 
established the presence of an N-terminal 26 residues 
signal peptide [ 11. After its excision by a signal pep- 
tidase, the remaining portion of the molecule was 
shown to contain an N-terminal segment composed of 
103 amino acids [ 21 separated from corticotropin 
and carboxy-terminal fl-lipotropin by a pair of basic 
residues [2]. The N-terminal segment of proopiomel- 
anocortin contains a structure which bears marked 
sequence homology with cr- and P-melanotropin thus 
it was termed y-melanotropin [2]. Pulse-chase xper- 
iments in rat pars intermedia [3] as well as in mouse 
AtT-20 tumor cells [4] showed that the N-terminal 
fragment of pro-opiomelanocortin does not mature 
appreciably [ 51 into smaller fragments during the first 
4 h of chase incubation. Such an observation could 
mean that it would be possible to isolate from pitu- 
itary extracts this N-terminal fragment in sufficient 
amounts to be completely characterized. Results 
obtained from crude extracts of ox pituitaries [6] 
indicated that virtually no maturation of the N-ter- 
minal peptide is observed in anterior pituitaries 
whereas -50% of this peptide matures into smaller 
fragments in pars intemredia cells. 
Utilizing the observation that the sequence of the 
N-terminal fragment of ox and rat [ 1,2] had identical 
positions of cysteine residues, a microsequencing 
method was used to monitor the complete purifica- 
tion of such a peptide from whole human pituitaries 
[7,8]. In [9], the N-terminal fragment of pro-opio- 
melanocortin from whole pig pituitaries was isolated 
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and partially characterized. We report here the purifi- 
cation of a N-terminal peptide of 103 amino acids from 
pig anterior pituitaries extracts. It is shown that its 
y-melanotropin segment is identical in composition to 
both ox [2] and man [7,8] homologues. Furthermore, 
primary structure determination revealed the presence 
of 2 glycosylation sites similar to the results obtained 
from rat pars intermedia biosynthetic studies [lo]. 
2. Materials and methods 
2.1. Isolation of the N-terminal fragment of pro-opio- 
melanocortin from porcine anterior pituitaries 
Porcine pituitary glands obtained within 30 mm of 
death were dissected into anterior and neurointer- 
mediate lobes and immediately frozen on dry ice. 
Extractions were performed at 4°C in 0.2 M HCl. Fol- 
lowing acetone precipitation and centrifugation, the 
precipitate obtained was subsequently chromato- 
graphed on CM-cellulose [ 111. The unretained mate- 
rial was resolved by high-performance liquid chro- 
matography (HPLC) on a Waters Associates liquid 
chromatograph using a &s column eluted with a 
triethylamine phosphate/acetonitrile gradient, as 
in [12]. 
2.2. Amino acid analysis and microsequencing 
Microsequencing of the N-terminal fragment puri- 
fied was done on the reduced and carboxymethylated 
material with iodo-[‘4C]acetamide as in [5]. Amino 
acid analysis of the reduced and carboxymethylated 
peptide was done in triplicate on a Beckman 12 1 MB 
amino acid analyser 24,48 and 72 h hydrolysis. 
Glucosamine and galactosamine are well separated in 
this system [ 51. 
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~~~~~X~~~h~~~~~ [5f raxmirlai fragment of 
pro~pi~meiano~o~in (2 mg) was digested for 7 h at 
3’7OC with XC-treated trypsin, This was fallowed by 
HPLC ~u~fication on a r~-Cra column f12j. The vari- 
ous peptides collected {see fig.1) were ~~d~~dually 
repurified under the same conditions, hydrolysed and 
subjected to amino acid analysis (see table 1). 
The &h~a~teri~ation of such isolated peptide was 
thus undertakes. Amino acid analysis gave the folIow- 
ing results: 
Lys (3), Ris (I), Arg (8) SCMC (4), Asp (9), Thr 
(4), Ser (lo), Glu (12), Pro (8), Gly (17), Ala (7), 
Val(3), h4et (l), Ile (l), Leu (8), Tyr (l), Ph (4), 
Trp (2). 
Glucosamine and galactosamine w re shown to be 
present at XZ 1. These results how that this peptide 
is glycosylated and is 103 amino acids long like the 
bovine f2], murine f4I and human [7,8] horn~~~g~e~= 
Atkr C~~e~~~~~ ~hro~atogra~~~~ the unn- Following trypsin digestion and peptide mapping 
tained material was purified by EfPLC and the various by HPLC (fig1 ), nine major tryptic fragments 
peptides obtained screened by radioactive micro- (I?,--T,) were purified and their amino acid composi- 
s~q~e~~i~g for the presence of Cys 2,8,20 and 24. A tion ~eterrn~~~ (table 1). Fig.2 shows the proposed 
peptide was thus purified possessing such a sequence. alignment of amino acids in this molecule compared 
Identical cysteine positions have been described for to the reported bovine sequence [Z]. The sum of 
the NWminal portion of pro-opiamelsnocortin from tryptic fragments TS-T, have an identical amino acid 
ox [Z], mouse [ 131 and man [4,5]. A computer data composition to the reported y-melanotropin segment 
bank search indicated that the probability of finding in ox [2] and man [7,8] indicating conservatian of
an identical partial sequence in other known proteins this structure between species. However, a number of 
or segments of proteins was <0.0004% (we thank amino acid s~bstitu~ons were observed in fragments 
I.& Mi Dayhoff for this search) 6: f 4 J + Ti, T3, T4, Ta and Ta (fIg,2), In agreement with (3 JY 
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Table 1 
Ammo acid composition of tryptic fragments of porcine N-terminal segment Of pro-OpiOm~~~O~O~~i~ 
Ammo acid T, T, T, T, T, T, T, T* T, 
LYS 1.17 (1) 1.77 (2) 
His 0.78 (1) 
Arg 1.09 (1) 1.02 (1) 0.70 (1) 0.83 (1) 1.00 (1) 1.67 (2) 1.72 (2) 
SCMC 2.21 (2) 1.22 (1) 0.60 (1) 1.22 (1) 
Asp 2.21 (1) 4.22 (4) 4.26 (4) 0.89 (1) 0.85 (1) 
Thr 1.03 (2) 1.15 (2) 1.91 (2) 
Ser 3.50 (3) 1.25 (1) 1.22 (1) 1.94 (4) 
Glu 4.24 (4) 2.89 (4) 3.05 (4) 0.77 (1) 4.20 (4) 
Pro 4.73 (5) 4.70 (5) 1.56 (2) 
GLY 2.26 (2) 2.09 (2) 1.15 (1) 1.23 (1) 7.71 (4) 3.46 (3) 
Aia 1.06 (1) 2.80 (2) 2.53 (2) 1.04 (2) 1.52 (1) 
Met 0.87 (1) 0.96 (1) 1.15 (1) 0.84 (2) 
Be 1.00 (1) 
Leu 4.21 (4) 1.86 (2) 2.09 (2) 
Tyr 0.78 (1) 
Phe 0.91 (1) 1.04 (1) 0.90 (1) 1.00 (1) 
Trp 1 .oo (1) 1.00 (1) 
Glucosamine 0.08 0.13 1 .oo 
Galactosamme 0.26 0.21 0.12 
Fragment 1-18 19-22 23-49 23-50 51-57 58-60 61-64 65-77 79-82 
(x) Expected from bovine cDNA sequence [21 
BOVINE 1:~ Cys teu GIU Se Ser Gin Cys Gs Asp Leo Thr Thr Glu Ser Asn Leu LeU 
D PORCINE Trp Cyr Lcu Gli Scr Ser Glx Cys Glt Asi leu Spr Thr Glx Ser Asr Leu LeU 
t---- n I 
ii Cys ile Ar9 Ala Cyr tys Pm Aq teu Ser Ala Giu Thr Pm MI Pht Pro 
Alo Cys fle Ar9 Alo Cys Lyi Pm Afx Lee SW Alo Glx Thr Pro VM Phe Pro 
L-..“__T’) * 
$0 A:9 Gly Asp Asp Ala Glu Thr Gly Pfo “r9 Glu Asp 
Pro Ar9 lSer,, Gly,, Leu2, Asi, Thr. Pm, Phef 
Fig.2. Proposed sequence of the N-terminal fragment of ante- 
rior pituitary porcine pro-opiomelanocortin. The sequence 
deduced from residues l-92 was based on comparison of 
ammo acid composition of peptides ‘PI-T,, to their homolo- 
gues bovine peptides [ 21 assuming maximum sequence 
homology and barring sequence inversions. The carboxy- 
terminal 11 ammo acid peptide composition was deduced by 
the difference between the total amino acid composition of 
the native N-terminal peptide and that obtained from the 
sum of compositions of peptides T,-T,. (*) Proposed gly- 
cosylation sites. 
Tr shows that in porcine Sertl replaces Thrra in the 
bovine homologue. Also the res. 15 was shown to be 
Ser. However, the finding of Glue is in disagreement 
with the Asp, reported 191. This conclusion was 
reconfirmed by direct sequencing (not shown). 
Hexosamine analysis of the tryptic fragments 
revealed the presence of a glucosamine-rich moiety in 
the peptide TB and a galactosamine-rich moiety in frag- 
ments T3 and T4. On the basis of the suggestion that 
Asn-linked sugars are rich in glucosamine and gener- 
ally occur within an Asn-X-Ser or Thr segment, 
where X could be any ammo acid [ 151, it is proposed 
that the glycosylation site in Ts is Asn6s (fig.2). The 
presence of large amount of galactos~~e compared 
to glucosamine in peptides T3 and T4 would argue 
against an Asn glycosylation site in these peptides 
[ 161. Furthermore, ammo-terminal sequence deter- 
mination of the first 35 residues of a similar peptide 
extracted from whole porcine pituitaries revealed the 
presence of Asp,,, Serz9 and Thra2 [9], therefore 
eliminating the possibility of glycosylation at these 
residues. We suggest that the only other possible site 
of glycosylation would be Thr4s_ In accordance with 
such a hypothesis, O~lycosylation on either Ser or 
Thr usually occurs in a Pro-rich region and contains 
ga~cto~rn~e as the major hexosamine [ 151. This is 
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exactly what we found in peptide Ta and T4. 
That bovine pituitary peptides are immunoreactive 
for the y-melanotropin sequence and bind to con- 
canavalin A [6] is indicative that the N-terminal seg- 
ment of proopiomelanocortin is glycosylated, but no 
direct experimental clues as to the site(s) of glycos- 
ylations can be deduced. Based on our findings of 
2 glycosylation sites on both sides of the y-melano- 
tropin sequence, the immunoreactive glycopeptide 
isolated [6] can be either a y-melanotropin with an 
N-terminal extension and/or a C-terminal extension, 
thus making it more difficult to assess the site of 
glycosylation on their isolated material. 
Our data, based on chemical characterization, 
demonstrate not only that the N-terminal fragment of 
pro-opiomelanocortin is a major product of matura- 
tion and is definitely a glycopeptide, but also that its 
sequence is quite homologous to similar peptides in 
ox [2] and man [7,8]. Moreover, it has two sites of 
glycosylation probably at Thrd5 and Asn,,. 
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